Center for Global Infectious Disease Research
Help Support Critical Work Addressing the Global Pandemic
The rapid global spread of SARS-CoV-2 has exposed inadequacies in our nation’s ability to respond to viral epidemics. COVID-19 has claimed hundreds of thousands of lives globally, and infected millions. In response to this urgent public health crisis, the Center for Global Infectious Disease Research (CGIDR) has initiated research studies to: monitor our workforce for infection and their responses, understand why adults and children are differently impacted by infection, develop new therapeutic treatment and prevention strategies, and to support critical vaccine studies. Your support is critical to advance these studies. Please consider giving to CGIDR to support this essential work.
Accelerating Progress Toward Cures
Our internationally recognized researchers are working collaboratively across scientific disciplines to examine the coronavirus from all angles so we can understand why it affects children differently than other populations.
Learn more about research on how nanobodies produced by a llama’s immune system can be used to develop a therapy that eliminates COVID-19 in humans.
Learn how new research may help identify new strategies to block the transmission of the malaria parasite.
Dr. Nana Minkah who contracted malaria multiple times as a child now dedicates life's work to eliminating this deadly disease.
Seattle Children’s Research Institute is one of three recipients of $30 million in first-year funding provided by the National Institutes of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to establish centers of immunology research to accelerate progress in TB vaccine development.
Matthew Wood shares insights from a recent publication in The Journal of Infectious Disease with contributing authors from the Sodora Lab at the Center for Global Infectious Disease Research.
COVID-19 Research Underway at Seattle Children’s Research Institute
Collaborations and partnerships are integral to CGIDR’s approach. Our investigators work closely with colleagues at the University of Washington, Fred Hutchinson Cancer Research Center and other institutions.
Participate in Research
Help us answer questions about childhood health and illness, and help other children in the future. Learn more.
Developing groundbreaking treatments takes more than just the right ideas. It also takes the right people – and the CGIDR is recruiting new members.
- Dr. Alexis Kaushansky Named to Puget Sound Business Journal’s 40 Under 40 List
This annual award spotlights individuals who are among the brightest and most innovative leaders under the age of 40. Dr. Alexis Kaushansky leads an interdisciplinary team that develops new ways to combat deadly infectious disease.
Answering your questions about malaria
Drs. Alexis Kaushansky, Ashley Vaughan and Maria Bernabeu Aznar answered questions about malaria in a Reddit Ask Me Anything on April 25, 2019, World Malaria Day.
- CGIDR awards five catalytic projects
These five projects are deemed to be catalytic because they are innovative, demonstrate the potential for new funding and promote new collaborations between the center’s researchers and laboratories.